Garlic Herpes?

There have been reports that garlic helps in providing a cure for herpes.

Do you think this is true? Is there a possibility that this kind of treatment can work?


Possible New Cure for Herpes

A new vaccine is being developed that may offer a potential way to cure painful cold sores and shingles.

Scientists may have found a new treatment for herpes that can flush the virus out from the body altogether. (more…)

Jessica Alba has Herpes?

We’ve been seeing a trend lately that there’s a rumor going around that one of our favorite celebrities, Jessica Alba has herpes.

Is this true? We went looking out to the web and found that she allegedly got it after dating the new York Yankees star, Derek Jeter. And this is all over the news. A source who worked as Jessica’s assistant at the time claims they had to replenish her Valtrex prescription – a treatment for genital herpes – on a regular basis, according to website L.A. Rag Mag.

True or not, herpes is a serious thing and if a celebrity who has the ability to attract a lot of relationships has it, he or she has to be extra careful when it comes to their encounters because you shouldn’t be really spreading the disease. Herpes is a disease that can be transmitted even when there are no visible symptoms and there is definitely no herpes cure.

But if you have it and you’re looking for some help, click this: Yes, Please Help Me Fix My Symptoms

Ebola Treatment Saves Monkeys

Things are starting to really speed up when it comes to testing this incredibly new but experimental drug called ZMapp. If you have been following the news regarding the Ebola epidemic that is currently spreading in Africa, you’d know that people are desperately trying to get some help to fight off this truly deadly virus.

According to some health organizations, it’s currently estimated that this epidemic will probably take many months to stop and will probably cost thousands of lives in the continent. The outbreak is currently occurring in countries like Liberia, Sierra Leone and Guinea.

But it’s not yet a total loss. In recent weeks, for example, two health workers were given the experimental drug ZMapp, which caused them to recover from the disease quite dramatically despite the fact that their symptoms were already advancing to the point where people do not normally survive.

So now, the race is on to get this drug tested fast and get it produced to save the lives people that are threatened with infection.

Recently, the drug has been the reason for the survival of at least seven people who have been infected with Ebola. And now, it has been tested with some macaque monkeys who have been infected with the virus.

According to the article on the LA Times, the monkeys were already five days into the infection. Researchers say that this would put them about three days from death. After being administered with the drug, the symptoms disappeared and the spread of the virus was contained and reduced to “insignificant levels.”

Sadly for three monkeys for whom the drugs were not administered, these died within eight days.

The tests were done in April and May by the Canadian Public Health Agency’s national laboratory for zoonotic diseases and special pathogens (quite a mouthful, yes). It was led by Gary P. Kobinger who was also joined by other researchers and scientists from the company that developed ZMapp, MappBio.

According to the team, the medication recognizes the Ebola virus and binds to it and according to Kobinger, this was “fantastic news.” He also added that the infection that the monkeys suffered from is pretty close to how humans progress when infected by the disease.

The experiment used a modified version of ZMapp and administered in much higher doses to infected patients.

Patients who are suffering from the viral infection develop symptoms such as fever, reduced appetite, and liver and skin problems. For humans, between the time of infection and death takes about twelve to fourteen days. The great news was, the experimental medication was able to rescue all of the 18 monkeys the drug was administered with.

This is pretty awesome news in the field of viral research and we truly encourage all of the researchers to keep going.









More Money is Pouring Into Herpes Vaccine Research

Here’s an interesting tidbit of news. It was announced yesterday that Admedus, which is a biotech company known formerly as Allied Healthcare, invested about an additional six million dollars into Admedus Vaccines.

Why is this a relevant development in the field of herpes research? Well, Admedus Vaccines is headed by one of the foremost medical researchers in the world and also the person responsible for the creation of the HPV vaccine, Professor Ian Frazer.

Just where are we with herpes vaccine research then? Well, if you haven’t been following the news lately, you would be pleased to know that in February, a vaccine for the Herpes Simplex 2 virus was being tested and Admedus released a statement that informed the public that there were really positive results from the Phase I trials that they have conducted.

We can expect more information from them soon regarding the result of those trials.

The company is scheduled to report additional data from the trial this quarter.

According to Lee Rodne, chief executive of Admedus, they were being quite “dedicated to the continued development of these programs” because of the immense potential of these solutions to help so many around the world suffering from a variety of illnesses, and not just herpes. However, the focus here is HSV-2, which is really the widespread version of the disease that causes genital herpes.

The goal of Professor Frazer’s team is to clear the virus out of the diseased person’s bloodstream. While this does not mean that they will be completely free of the virus, it would really reduce the occurrence of outbreaks and reduce the potential for spreading the virus.

Herpes remains one of the most widespread sexually transmitted diseases in the adult world mainly because it still is a disease for which there is no cure. Antiviral medications are available to treat it but they only work to suppress symptoms but not really clear it from a person’s body.

It looks like there is really still some progress being made in herpes research and we really look forward to the day when it is finally cured. When that happens, we can expect ventures like Admedus Vaccines to be awash in business from the millions of people who would gladly pay to be rid of this disease.

In the meantime, it would be best if we still stick to healthy routines and keep those symptoms in check.